This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Suzhou Connect Biopharmaceuticals, Ltd.. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2024
Title: Jie Jiang - Innovator in Biopharmaceuticals
Introduction
Jie Jiang is a prominent inventor based in Taicang, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibodies. With a total of 2 patents to his name, Jiang is recognized for his innovative approaches to medical applications.
Latest Patents
Jiang's latest patents focus on antibodies capable of binding to the interleukin 4 (IL-4) receptor. These patents disclose a nucleic acid sequence encoding the antibody, a vector that includes this sequence, and a host cell that has been transformed or transfected with the vector. Additionally, the patents provide methods for producing the antibody, its medical uses, and kits that include the antibody.
Career Highlights
Jie Jiang is currently associated with Suzhou Connect Biopharmaceuticals, Ltd., where he continues to advance his research and development efforts. His work is pivotal in the biopharmaceutical industry, contributing to the understanding and treatment of various medical conditions.
Collaborations
Jiang collaborates with notable colleagues such as Wei Zheng and Wubin Pan, enhancing the innovative capacity of his team. Their combined expertise fosters a productive environment for groundbreaking research.
Conclusion
Jie Jiang's contributions to the field of biopharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile